NCDR Real World Evidence
Customizable Insights for Industry Leaders
The ACC Real World Evidence (RWE) program allows you to turn its data into action. By using the unmatched depth and data quality of the NCDR you can get tailored data and analysis that is recognized by authorities worldwide.
Our customizable insights support innovation and growth in key areas:
- Medical devices
- Cardiovascular treatments
- Improved quality of care
- Demonstrating geographic variations in care
- Identifying treatment trends
Who Benefits and How?
Gain valuable insights into treatment patterns, patient outcomes and health trends, which support evidence-based innovation and product development.
Use its insights to assess care quality, optimize resource allocation and support value-based reimbursement strategies.
Gain insights into device performance, adoption trends and patient outcomes, enabling them to enhance product development and innovation.
Use insights to inform policies, improve health equity and enhance the overall quality of cardiovascular care.
Assess insights that inform clinical guidelines, support education initiatives and promote advancements in cardiovascular care.
Interested in a Customizable Analysis?
NCDR custom analytics meet privacy and security regulations, such as those outlined in the Health Insurance Portability and Accountability Act (HIPAA) and follow appropriate national standards for relationships with industry engagement.